Drug Type Monoclonal antibody |
Synonyms PM 1015, PM-1015 |
Target |
Action inhibitors |
Mechanism CD73 inhibitors(5-nucleotidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | China | 10 May 2022 | |
Liver Cancer | Phase 1 | China | 10 May 2022 |